Consensus Keurig Dr Pepper Inc.

Equities

KDP

US49271V1008

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
33.72 USD -0.35% Intraday chart for Keurig Dr Pepper Inc. +7.05% +1.20%

Evolution of the average Target Price on Keurig Dr Pepper Inc.

Price target over the last 5 years

History of analyst recommendation changes

5efc995cdde6876c922436.NSD8A3l2zKQ9HkB7N3ivNLma7DHhPZ8EyavJHe3HmhU.fEbRUQkk-vMLb3JMXy7fTtb9tF6qSsZ8oe6nc5ik_3ZBbMtlLBu88mxOEQ~56aec03895cb119661bd93eb32223e48
JPMorgan Adjusts Keurig Dr Pepper's Price Target to $37 From $34 MT
Jefferies Adjusts Keurig Dr Pepper's Price Target to $39 From $35 MT
Wedbush Adjusts Keurig Dr Pepper's Price Target to $37 From $35 After 'Strong' Q1 Beat, Keeps Outperform Rating MT
UBS Adjusts Keurig Dr Pepper Price Target to $39 From $36, Maintains Buy Rating MT
TD Cowen Adjusts Keurig Dr Pepper's Price Target to $35 From $32 MT
Bernstein Adjusts Price Target on Keurig Dr Pepper to $39 From $36 MT
Morgan Stanley Adjusts Price Target on Keurig Dr Pepper to $36 From $34 MT
Wells Fargo Adjusts Price Target on Keurig Dr Pepper to $39 From $37 MT
Barclays Raises Keurig Dr Pepper's Price Target to $38 From $36 MT
Citigroup Adjusts Price Target on Keurig Dr Pepper to $35 From $33 MT
Evercore ISI Adjusts Keurig Dr Pepper Price Target to $36 From $34, Keeps In Line Rating MT
Deutsche Bank Adjusts Keurig Dr Pepper Price Target to $34 From $33, Maintains Hold Rating MT
Consumer Edge Adjusts Keurig Dr Pepper's Price Target to $41 From $40 MT
Barclays Adjusts Price Target on Keurig Dr Pepper to $36 From $32, Maintains Overweight Rating MT
Jefferies Cuts Keurig Dr Pepper's Price Target to $35 From $37, Keeps Buy Rating MT
Barclays Cuts Price Target on Keurig Dr Pepper to $32 From $34, Keeps Overweight Rating MT
ANALYST RECOMMENDATIONS : Block, Estee Lauder, Dell, Netflix, Nvidia... Our Logo
Morgan Stanley Cuts Price Target on Keurig Dr Pepper to $34 From $37, Keeps Equalweight Rating MT
Wedbush Lowers Keurig Dr Pepper's PT to $35 From $37 After Mixed Q4 2023 Results, Maintains Outperform Rating MT
Barclays Cuts Price Target on Keurig Dr Pepper to $34 From $37, Maintains Overweight Rating MT
Deutsche Bank Trims Keurig Dr Pepper Price Target to $33 From $34, Maintains Hold Rating MT
RBC Trims Price Target on Keurig Dr Pepper to $41 From $42, Keeps Outperform Rating MT
UBS Cuts Price Target on Keurig Dr Pepper to $36 From $38, Maintains Buy Rating MT
UBS Adjusts Keurig Dr Pepper Price Target to $38 From $37, Maintains Buy Rating MT
Morgan Stanley Downgrades Keurig Dr Pepper to Equalweight From Overweight, Price Target is $37 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
33.72 USD
Average target price
35.96 USD
Spread / Average Target
+6.64%
High Price Target
41 USD
Spread / Highest target
+21.59%
Low Price Target
27 USD
Spread / Lowest Target
-19.93%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Keurig Dr Pepper Inc.

JPMorgan Chase
Jefferies & Co.
Wedbush
UBS
TD Cowen
Bernstein
Morgan Stanley
Citigroup
Wells Fargo Securities
Barclays
Evercore ISI
Deutsche Bank Securities
Consumer Edge
RBC Capital Markets
Goldman Sachs
Credit Suisse
Truist Securities
Guggenheim
Cowen
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock Market
  2. Equities
  3. KDP Stock
  4. Consensus Keurig Dr Pepper Inc.